Medtech startup Bioliberty has launched Lifehub Clinic, which is a portable, modular solution to assist therapists with delivering high-intensity, engaging therapy in clinical settings.
This system will serve as a hub for a portfolio of Bioliberty soft-robotic wearables and gamified therapy solutions to address unmet needs in patient recovery following neurological injury or impairment.
In addition to advancing new wearable technologies, Bioliberty plans to extend therapy beyond traditional settings, while leveraging AI to enable more individualised treatment.
Initially, Lifehub Clinic will focus on upper extremity therapy leveraging Bioliberty’s soft-robotic wearable, Lifeglov. Powered by air, the glove provides controlled assistance to open the hand, calibrated to each patient’s individual functional ability.
Wearing the glove, patients engage in high-dose, repetitive task practice through interactive, game-based exercises, an approach designed to promote neuroplasticity and restore movement. This supports individuals with impaired hand use, such as those recovering from stroke, in regaining limb function.
Rowan Armstrong, the co-founder and chief executive officer at Bioliberty, said: “In developing Lifehub Clinic, we collaborated closely with leading physical rehabilitation centers to identify solutions to real-world challenges faced by real stroke patients.
“As a result, we’ve developed a clinically robust solution that is intuitive and engaging for users, while addressing the underlying challenges these patients face.”
Clinicians using Lifehub Clinic can monitor patient progress through the Lifemind software suite. This browser-based analytics platform offers important insights into therapy frequency, duration, and the overall effectiveness of each patient’s treatment journey.
While currently focused on supporting therapy goal setting to maximise patient outcomes and provider time, Bioliberty says that Lifemind will soon harness AI to streamline clinical workflows, reduce the documentation burden for physical and occupational therapists, and help providers leverage therapy data to support compliant, optimised reimbursement.
Bioliberty previously secured a £435,000 investment from the Biomedical Catalyst, Innovate UK’s flagship grant funding mechanism.
The post Portable modular solution aims to transform therapy through soft robotics and gamified exercises appeared first on AT Today – Assistive Technology.